Technical Analysis for GLMD - Galmed Pharmaceuticals Ltd.

Grade Last Price % Change Price Change
grade F 6.42 -0.93% -0.06
GLMD closed down 0.93 percent on Friday, May 24, 2019, on approximately normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical GLMD trend table...

Date Alert Name Type % Chg
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Down 5 Days in a Row Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Stochastic Reached Oversold Weakness -0.93%
Down 3 Days in a Row Weakness -0.93%
Down 4 Days in a Row Weakness -0.93%
Down 5 Days in a Row Weakness -0.93%
Oversold Stochastic Weakness -0.93%
Down 3 Days in a Row Weakness -4.18%

Older signals for GLMD ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
GalMed Medical Research Ltd. researches and develops proprietary drugs for the treatment of lipid metabolism related diseases. The company has developed a series of proprietary fatty acid bile-acid conjugates (FABACs) which selectively inhibit the enzyme Stearoyl-CoA Desaturase (SCD1), a key regulator in lipid metabolism. It's flagship clinical compound Aramchol (arachidyl amido cholanoic acid), has the potential to modify several of the key disorders related to lipid metabolism, including fatty liver, gallstones, diabetes, hyperlipidemia, cancer, and alzheimer's disease. The company is based in Tel Aviv, Israel. GalMed Medical Research Ltd. operates as a subsidiary of Galmed International Ltd.
Cancer Diabetes Alzheimer's Disease Hepatology Lipid Hyperlipidemia Metabolism
Is GLMD a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 27.06
52 Week Low 5.58
Average Volume 94,270
200-Day Moving Average 9.3838
50-Day Moving Average 7.8938
20-Day Moving Average 7.105
10-Day Moving Average 6.722
Average True Range 0.4286
ADX 31.8
+DI 9.0236
-DI 23.6515
Chandelier Exit (Long, 3 ATRs ) 7.2196
Chandelier Exit (Short, 3 ATRs ) 7.6458
Upper Bollinger Band 8.0244
Lower Bollinger Band 6.1856
Percent B (%b) 0.13
BandWidth 25.880366
MACD Line -0.3882
MACD Signal Line -0.3564
MACD Histogram -0.0317
Fundamentals Value
Market Cap 78.45 Million
Num Shares 12.2 Million
EPS -1.22
Price-to-Earnings (P/E) Ratio -5.26
Price-to-Sales 98.60
Price-to-Book 15.87
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 7.31
Resistance 3 (R3) 7.38 7.17 7.16
Resistance 2 (R2) 7.17 6.94 7.13 7.11
Resistance 1 (R1) 6.79 6.80 6.69 6.72 7.06
Pivot Point 6.58 6.58 6.52 6.54 6.58
Support 1 (S1) 6.20 6.35 6.10 6.13 5.78
Support 2 (S2) 5.99 6.21 5.95 5.73
Support 3 (S3) 5.61 5.99 5.68
Support 4 (S4) 5.54